Cargando…
A novel lysosome-related gene signature coupled with gleason score for prognosis prediction in prostate cancer
Background: Prostate cancer (PCa) is highly heterogeneous, which makes it difficult to precisely distinguish the clinical stages and histological grades of tumor lesions, thereby leading to large amounts of under- and over-treatment. Thus, we expect the development of novel prediction approaches for...
Autores principales: | Huang, Ying, Yang, Fan, Zhang, Wenyi, Zhou, Yupeng, Duan, Dengyi, Liu, Shuang, Li, Jianmin, Zhao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098196/ https://www.ncbi.nlm.nih.gov/pubmed/37065491 http://dx.doi.org/10.3389/fgene.2023.1135365 |
Ejemplares similares
-
The Development of a Gleason Score-Related Gene Signature for Predicting the Prognosis of Prostate Cancer
por: Yimamu, Yiliyasi, et al.
Publicado: (2022) -
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
por: Geybels, Milan S., et al.
Publicado: (2016) -
Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score
por: Shou, Yanhong, et al.
Publicado: (2020) -
Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort
por: Jhun, Min A., et al.
Publicado: (2017) -
The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)